Home Delivery Service 0800 031 5406
Medical Helpline 0800 031 5412

Form of permanent radiotherapy may prolong prostate cancer survival, study finds

According to study author Prof. James Morris of the Vancouver Cancer Centre at the British Columbia Cancer Agency (BCCA) in Canada, this is the first study to compare the two techniques in the treatment of prostate cancer.

The American Cancer Society state that both low-dose-rate prostate brachytherapy (LDR-PB) and dose-escalated external beam radiotherapy (DE-EBRT) are considered to be effective treatments for prostate cancer, though they note there is more information on the outcomes of the latter. For more information please visit MNT Website